Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STRO · against 191 other Healthcare companies of similar size
Ranked #174 of 192 · scores higher than 9% of peers · safety percentile 4
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)27 peers with a safety percentile of 0–9, including STRO · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | STRO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 170 reported | Not reported | 0.21× | — | — | 33% |
| BetaLower is better · 181 reported | 1.49 | 0.61 | 16% | 33% | |
| Current ratioHigher is better · 188 reported | 3.32× | 2.95× | 54% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 165M USD | 99 | 50 | |
| 3 | 261M USD | 99 | 97 | |
| 4 | 284M AUD (≈$188M) | 98 | 36 | |
| 5 | 213M USD | 98 | ||
| 170 | 251M EUR (≈$276M) | 7 | 52 | |
| 171 | 296M USD | 5 | 66 | |
| 172 | 222M GBP (≈$288M) | 5 | 13 | |
| 173 | 79M EUR (≈$87M) | 5 | 25 | |
| 174 | 158M USD | 4 | 14 | |
| 175 | 172M USD | 4 | 34 | |
| 176 | 1.91T IDR (≈$119M) | 4 | 26 | |
| 177 | 172M USD | 4 | 3 | |
| 178 | 107M USD | 3 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score